Donor lymphocyte infusions after reduced intensity conditioning allogeneic transplantation: what we need to know.
Marks
David I
DI
Parker
Anne
A
Robinson
Stephen P
SP
D002986:Clinical Trials as Topic; D006086:Graft vs Host Disease / Q000276:immunology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D007938:Leukemia / Q000276:immunology / Q000473:pathology / Q000628:therapy; D017710:Lymphocyte Transfusion / Q000009:adverse effects; D008223:Lymphoma / Q000276:immunology / Q000473:pathology / Q000628:therapy; D018183:Transplantation Chimera / Q000276:immunology; D019172:Transplantation Conditioning / Q000379:methods*